Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by International Business Times referenced an article published in a supplement to The American Journal of Managed Care® (AJMC®), titled “Economic Burden of Alzheimer Disease and Managed Care Considerations.” In assessing the financial burden of Alzheimer disease, researchers said that unless new treatments or cures are developed, current treatment costs of $305 billion per year will rise to more than $1 trillion by 2050.
A piece by The Week spotlighted a video interview published on AJMC.com, the website of AJMC®. The interview, “Dr William "Andy" Nish Debunks Common Reasons for Not Getting COVID-19 Vaccine,” discussed false beliefs about COVID-19 vaccination, and why there is no good reason not to get inoculated, especially as the Delta variant spreads.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More